Actually the CDC voted to give the male Gardasil vaccination it's Permissive Recommendation which is just short of what they call their Routine Recommendation which is their highest recommendation. Difference is that if a parent with a boy goes to a doctor the doctor is not required to inform the parent of the availability of the vaccine unless the parent asks.
Also bear in mind that the FDA has only approved the male
HPV vaccine for the treatment of Genital Warts, NOT oral cancer since the only approved studies so far were for genital warts. That was the sticking point with the CDC and that's what I and others were there to try and persuade the inner circle of the ACIP (Advisory Committee on Immunization Practices)to look beyond and approve this vaccine for EVERYTHING that
HPV can cause in males not just the one thing the study included. Gardasil wanted to bring the male
HPV vaccine to market as fast as possible and if they had to do a study on
HPV and oral cancer that would have taken decades so they opted to study just genital warts which I believe only took 5 years.
Also keep in mind that one of the criteria that the ACIP MUST consider is the cost of Quality Adjusted Life Years (QALY) that adding this vaccine to a previously approved female vaccination program would cost. Also realize that if 100% of females were vaccinated then the cost to add the male vaccine would be the highest as the only beneficiaries could be what they called MSM (Men having Sex with Men). The Committee was presented with 5 different QALY studies which all started off with assuming a minimum of a 30% female vaccination rate (even though historically statistics show that only 17% of females get all 3 shots) and then going up from that. They also only considered the benefits of reducing the medical costs associated with eliminating male genital warts. So you can imagine, relatively speaking, the cost of QALY's was very high. Some studies did attempt to add the costs associated with oral, anal and penal cancers but the Committee was told that "UNTIL we are presented with proven data and the drug is approved for those diseases, we can not consider them in our recommendation."
The male vaccine is included in the federally funded VFC (Vaccine for Children) program which I believe means it's free to covered individuals but I assume only for what the FDA has approved the vaccine for which again is not for the Tx of oral cancer. I assume other insurance carriers would have the same limitations.